Patient Guide: A 52-week, Placebo- and Active- Controlled (Roflumilast, Daliresp® 500µg) Study to Evaluate the Efficacy and Safety of Two Doses of CHF6001 DPI (Tanimilast) as add-on to Maintenance Triple Therapy in Subjects With COPD and Chronic Bronchitis. (PILLAR)

Why Use Quri.ai for This Trial?

  • ✓ Simplified eligibility checker - know if you qualify in minutes
  • ✓ Direct contact with study coordinators at 460 locations
  • ✓ Plain language explanations of medical terms and procedures
  • ✓ Personalized enrollment support throughout your journey
  • ✓ Free service - no hidden fees or obligations
Trial ID: NCTNCT04636814
Status: ACTIVE_NOT_RECRUITING
Condition: Chronic Obstructive Pulmonary Disease
Phase: PHASE3

Where You Can Participate

This study is available at 460 locations across the country.

Top locations include:
  • • Andalusia, Alabama
  • • Foley, Alabama
  • • Guntersville, Alabama
  • • And 457 more locations

Loading interactive enrollment tools...

The full interactive experience will load momentarily

A 52-week, Placebo- and Active- Controlled (Roflumilast, Daliresp® 500µg) Study to Evaluate the Efficacy and Safety of Two Doses of CHF6001 DPI (Tanimilast) as add-on to Maintenance Triple Therapy in Subjects With COPD and Chronic Bronchitis. (PILLAR) - Join Clinical Trial NCTNCT04636814

How to Join This Clinical Trial - NCTNCT04636814

Learn how to participate in this PHASE3 trial studying an investigational therapy for Chronic Obstructive Pulmonary Disease. Current status: ACTIVE_NOT_RECRUITING.

Am I Eligible for This Clinical Trial?

This clinical research study is looking for participants with Chronic Obstructive Pulmonary Disease. Eligibility requirements include specific age ranges, health status, and medical history. Contact the study team to learn if you qualify.

Condition Being Studied
Chronic Obstructive Pulmonary Disease
Treatment Being Tested
Investigational treatment
Study Phase
PHASE3 - Large-scale efficacy study
Enrollment Status
ACTIVE_NOT_RECRUITING
Study Identifier
NCTNCT04636814 - ClinicalTrials.gov Identifier
Sponsored By
Study sponsor

What to Expect as a Participant

Participating in this clinical trial involves:

  • Initial screening to determine eligibility
  • Regular study visits and health assessments
  • Receiving the study treatment or placebo
  • Medical monitoring and follow-up care
  • Contributing to medical research that may help others
  • Potential access to new treatments before they're widely available

Clinical Trial Benefits and Compensation

Participants in this clinical research study may receive:

  • Close medical monitoring by healthcare professionals
  • Access to potential new treatments
  • Compensation for time and travel (varies by study)
  • No-cost study-related medical care
  • The opportunity to help advance medical knowledge

Where Is This Clinical Trial Located?

This study is enrolling participants at 460 locations. Find a study site near you:

Clinical Research Site

Andalusia, Alabama 36420-5310 - United States

Status: Contact for availability

Clinical Research Site

Foley, Alabama 36535-2248 - United States

Status: Contact for availability

Clinical Research Site

Guntersville, Alabama 35976-2206 - United States

Status: Contact for availability

Clinical Research Site

Mobile, Alabama 36608 - United States

Status: Contact for availability

Clinical Research Site

Saraland, Alabama 36571-3014 - United States

Status: Contact for availability

Clinical Research Site

Phoenix, Arizona 85018-5434 - United States

Status: Contact for availability

Clinical Research Site

Conway, Arkansas 72032 - United States

Status: Contact for availability

Clinical Research Site

Laguna Hills, California 92653-5509 - United States

Status: Contact for availability

Clinical Research Site

Los Angeles, California 90017-5649 - United States

Status: Contact for availability

Clinical Research Site

Newport Beach, California 92663-3661 - United States

Status: Contact for availability

And 450 more locations available. Contact us to find the nearest participating site.

How to Enroll in This Study

To learn more about participating in this PHASE3 clinical trial for Chronic Obstructive Pulmonary Disease:

  1. Review the eligibility criteria with your healthcare provider
  2. Contact the study team for a pre-screening interview
  3. Schedule an in-person screening visit if eligible
  4. Review and sign the informed consent form
  5. Begin participation in the clinical trial

Why Choose Quri.ai Study Finder

Quri.ai's Study Finder is the leading clinical trial business intelligence platform, helping BD professionals:

  • Discover clinical trials before competitors
  • Access exclusive contact information
  • Track sponsor pipelines and opportunities
  • Connect with decision makers directly
  • Win more business partnerships